<?xml version="1.0" encoding="UTF-8"?>
<p>According to the 7
 <sup>th</sup> edition of the diagnostic criteria [
 <xref rid="B25" ref-type="bibr">25</xref>], patients severely or critically ill with COVID-19 should receive comprehensive antiviral treatment, including lopinavir/ritonavir, arbidol, or Shufeng Jiedu Capsule. Meanwhile, they also need additional treatments, according to their symptoms, including respiratory support (oxygen therapy, high-flow nasal cannulas, or noninvasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation- (ECMO-) based therapy), circulatory support, or continuous renal replacement therapy. The main therapeutic approaches proposed for COVID-19 are summarized in 
 <xref rid="tab5" ref-type="table">Table 5</xref>.
</p>
